Delivery Order SPE2DR25D3004-SPE2DR26FXZF2
Award Date 3/2/26
Potential Completion Date 3/3/26
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $3,557.89 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Hydralazine 20 mg/ml vials, with an ultimate completion date of March 3, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. Pricing is firm fixed...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Hydralazine 20 mg/mL vials with a ceiling value of $3,214.90 under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is March 4, 2026. The order carries no set-aside designation and was competitively awarded.</p>
- The Defense Logistics Agency (DLA) awarded a $1,798.12 delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/ml vials, with a completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,545.87 to AmerisourceBergen Drug Corp for the supply of Hydralazine 20 mg/ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order is scheduled for completion by September 26, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Hydralazine is a vasodilator medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency issued a $1,987.20 delivery order to AmerisourceBergen Drug Corp on February 11, 2026, for Hydromorphone 1 mg/ml vials with an ultimate completion date of February 12, 2026. The order is issued under the parent DLA Troop Support Medical IDC (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. This vehicle supplies pharmaceutical products and medical commodities to support military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for hydromorphone 2 mg/ml vial supply with a ceiling value of $1,892.27. The order was issued under the parent Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date for this delivery order is February...
- The Defense Logistics Agency awarded a $126,270 delivery order to Amerisourcebergen Drug Corporation for 20 mg/mL vials of hydralazine. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide pharmaceutical products to DLA locations in the Philadelphia area. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four-day period concluding on July 21, 2023. No set aside designation or subcontractors...
- This delivery order for $843 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for the provision of 4562523622 units of Hydralazine 20 MG/ML Vial/ML by October 19, 2023. The contract vehicle is a firm fixed price agreement with no set-aside designation. The place of performance will be Amerisourcebergen's corporate office located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the global supply chain for the United States military and supports its...
- This federal contract award is a delivery order (SPE2DB20D3103|SPE2DB25FL6E6) from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4566406249 - Hydralazine 20 mg/ml vial/ml. The $6,809.93 firm fixed-price contract has a completion date of November 13, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation. This award is part of a larger $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,441.58 firm-fixed-price contract is for the supply of 4565904283 - Hydralazine 20 mg/ml vials. It is not a set-aside contract. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which covers a broad range of pharmaceutical and medical commodities to support...